 BOULDER, Colo., Nov. 03, 2022 GLOBE NEWSWIRE -- Fresh Tracks Therapeutics, Inc. Fresh Tracks Therapeutics or the Company Nasdaq: FRTX, a clinical-stage pharmaceutical company aiming to disrupt existing treatment paradigms by developing innovative and differentiated prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases, today announced that it will report its third quarter financial results on Thursday, November 10th. Company management will host a conference call and webcast at 4:30 p.m. EST that same day to discuss the financial results and recent corporate highlights. 